IMMUCELL CORP /DE/ Logo

IMMUCELL CORP /DE/

Develops biotech health products for disease prevention in dairy and beef cattle.

ICCC | NDAQ

Overview

Corporate Details

ISIN(s):
US4525253062
LEI:
Country:
United States of America
Address:
56 EVERGREEN DR, 4103 PORTLAND
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ImmuCell Corporation is an animal health biotechnology company that develops, manufactures, and markets scientifically-proven products to improve the health and productivity of dairy and beef cattle. The company's flagship product line, First Defense®, delivers 'Immediate Immunity™' to newborn calves, utilizing colostrum-derived antibodies to prevent scours caused by E. coli, coronavirus, and rotavirus. A key differentiator is ImmuCell's unique capability to concentrate, purify, and quantify these specific antibodies on a commercial scale. The company is also developing Re-Tain®, a nisin-based intramammary treatment for subclinical mastitis, as an alternative to traditional antibiotics. ImmuCell focuses on providing practical, cost-effective solutions for disease prevention, aiming to maximize genetic potential and reduce antibiotic reliance in the food chain.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all IMMUCELL CORP /DE/ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMMUCELL CORP /DE/

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMMUCELL CORP /DE/ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BioAge Labs, Inc. Logo
Develops therapies for metabolic diseases like obesity by targeting the biology of human aging.
United States of America BIOA
BioArctic Logo
Develops treatments and diagnostics for neurodegenerative disorders like Alzheimer's and Parkinson's.
Sweden BIOA
BioAtla, Inc. Logo
Developing safer, conditionally active antibody therapies for solid tumor cancers.
United States of America BCAB
BioCardia, Inc. Logo
Developing regenerative cell therapies for cardiovascular and pulmonary diseases.
United States of America BCDA
Bioceltix S.A. Logo
Developing 'off-the-shelf' stem cell therapies for diseases in companion animals.
Poland BCX
BIOCRYST PHARMACEUTICALS INC Logo
Develops oral small-molecule drugs for rare diseases like hereditary angioedema.
United States of America BCRX
Biodexa Pharmaceuticals Plc Logo
Develops treatments for rare diseases, diabetes, and cancer using proprietary drug delivery tech.
United States of America BDRX
Biofarm S.A. Logo
A top domestic manufacturer of pharmaceuticals, supplements, and soft gelatin capsules.
Romania BIO
Biofrontera AG Logo
Biopharma firm specializing in photodynamic therapy for dermatological conditions like actinic keratosis.
Germany B8F
Biofrontera Inc. Logo
Biopharma firm commercializing photodynamic therapy & antibiotics for skin conditions.
United States of America BFRI

Talk to a Data Expert

Have a question? We'll get back to you promptly.